Middle East & Africa Endothelial Dysfunction Market Forecast to 2028 - Regional Analysis

List of Tables

The Middle East & Africa endothelial dysfunction market is expected to grow from US$ 62.11 million in 2022 to US$ 75.11 million by 2028. It is estimated to grow at a CAGR of 3.2% from 2022 to 2028.

Use of Non-invasive Methods to Assess Endothelial Dysfunction Fuels Middle East & Africa Endothelial Dysfunction Market

Endothelial dysfunction is a strong prognostic factor for cardiovascular events and mortality in the population. Assessment of endothelial function can aid in selecting therapies and assessing their response. While invasive angiography remains the gold standard for measuring coronary endothelial function, several noninvasive imaging techniques have evolved to study both coronary and peripheral endothelial function. Available endothelial testing methods are helpful for mechanistically understanding diseases and risk stratification and prognoses, such as high-resolution B-mode ultrasound and Doppler, computed tomography angiography, cardiovascular magnetic resonance (CMR), magnetic resonance imaging (MRI), and positron emission tomography (PET).

Noninvasive methods for assessing endothelial function are mainly used in scientific research since there is a significant risk of complications due to the specificity of endovascular interventions. One of the noninvasive methods to assess endothelial function is to measure fluorescence. Flow-mediated skin fluorescence (FMSF) is based on the fluorescence measurement of the reduced nicotinamide adenine dinucleotide (NADH) emitted by skin cells in response to UV light excitation. The test consists of three phases: recording the fluorescence's background intensity, occlusion phase, and reaction registration. FMSF allows the determination of tissue and vascular bed response during ischemia, while classical Flow-Mediated Dilatation (FMD) techniques are based on a study of vasomotor reactivity. The classic FMD method for assessing the intensity of reactive hyperemia comprises three phases: measurement of the diameter of a selected artery (e.g., brachial artery), stimulation phase, and measurement after stimulation. Reactive peripheral arterial hyperemia tonometry (RH-PAT) is a modified FMD method used in EndoPAT devices. The method has been extensively validated in numerous publications as a diagnostic and predictive tool for assessing vascular risk. The closed zone FMD method (EZ-FMD) is based on oscillometric blood pressure measurement.

Middle East & Africa Endothelial Dysfunction Market Overview

Middle East & Africa consists of countries such as Saudi Arabia, the UAE, South Africa, and the Rest of Middle East. The growth of the market is attributed to increasing cases of chronic diseases that are primary factors or endothelial dysfunction, growing collaborations between governments to enhance healthcare facilities in South Africa, and growing incidences of obesity.

Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

Middle East & Africa Endothelial Dysfunction Market Segmentation

The Middle East & Africa endothelial dysfunction market is segmented into cause, test type, end user, and country.

Based on cause, the Middle East & Africa endothelial dysfunction market is segmented into hypertension, hypercholesterolaemia, obesity, diabetes, behcet's disease, and others. The hypertension segment registered the largest Middle East & Africa endothelial dysfunction market share in 2022.

Based on test type, the Middle East & Africa endothelial dysfunction market is segmented into invasive test and non-invasive test. The invasive test segment held a larger Middle East & Africa endothelial dysfunction market share in 2022. The non-invasive test segment is further subsegmented into flow mediated dilatory, peripheral arterial tonometry (PAT), venous occlusion pletismography, circulating markers, and others.

Based on end user, the Middle East & Africa endothelial dysfunction market has been categorized into hospitals, diagnostic centers, clinics, and others. The hospitals segment held the largest Middle East & Africa endothelial dysfunction market share in 2022.

Based on country, the Middle East & Africa endothelial dysfunction market is segmented into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. The Rest of Middle East & Africa dominated the Middle East & Africa endothelial dysfunction market in 2022.

ZOLL Medical Corp, The Polymath Co, Perimed AB, SMART Medical Ltd, and Medizinische Messtechnik GmbH are some of the leading companies operating in the endothelial dysfunction market in the region.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa endothelial dysfunction market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa endothelial dysfunction market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the endothelial dysfunction market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Product Code: BMIRE00029159

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Middle East & Africa Endothelial Dysfunction Market - by Cause
- 1.3.2 Middle East & Africa Endothelial Dysfunction Market - by Test Type
- 1.3.3 Middle East & Africa Endothelial Dysfunction Market - by End User
- 1.3.4 Middle East & Africa Endothelial Dysfunction Market - by Country

2. Middle East & Africa Endothelial Dysfunction Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Middle East & Africa Endothelial Dysfunction Market - Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 Middle East and Africa PEST Analysis
4.3 Expert Opinion

5. Middle East & Africa Endothelial Dysfunction Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Incidences of Cardiovascular Diseases
- 5.1.2 Rising Incidences of High Cholesterol, Diabetes And Obesity
5.2 Market Restraints
- 5.2.1 Disadvantages Associated with the Techniques for Screening of Endothelial Dysfunction
5.3 Market Opportunities
- 5.3.1 Rising Usage of Novel Biomarkers and Therapeutic Strategies
5.4 Future Trends
- 5.4.1 Use of Noninvasive Methods to Assess Endothelial Dysfunction
5.5 Impact Analysis

6. Endothelial Dysfunction Market - Middle East & Africa Analysis

6.1 Middle East & Africa Endothelial Dysfunction Market Revenue Forecast and Analysis

7. Middle East & Africa Endothelial Dysfunction Market Analysis - by Cause

7.1 Overview
7.2 Middle East & Africa Endothelial Dysfunction Market, By Cause, 2022 & 2028 (%)
7.3 Hypertension
- 7.3.1 Overview
- 7.3.2 Hypertension: Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
7.4 Diabetes
- 7.4.1 Overview
- 7.4.2 Diabetes: Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
7.5 Hypercholestrolaemia
- 7.5.1 Overview
- 7.5.2 Hypercholestrolaemia: Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
7.6 Behcet's Disease
- 7.6.1 Overview
- 7.6.2 Behcet's Disease: Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
7.7 Obesity
- 7.7.1 Overview
- 7.7.2 Obesity: Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
7.8 Others
- 7.8.1 Overview
- 7.8.2 Others: Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

8. Middle East & Africa Endothelial Dysfunction Market Analysis - by Test Type

8.1 Overview
8.2 Middle East & Africa Endothelial Dysfunction Market, By Test Type, 2022 & 2028 (%)
8.3 Invasive Tests
- 8.3.1 Overview
- 8.3.2 Invasive Tests: Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
8.4 Non-Invasive Tests
- 8.4.1 Overview
- 8.4.2 Non-Invasive Tests: Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
- 8.4.3 Flow Mediated Dilatory
  - 8.4.3.1 Overview
  - 8.4.3.2 Flow Mediated Dilatory: Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
- 8.4.4 Venous Occlusion Plethysmography
  - 8.4.4.1 Overview
  - 8.4.4.2 Venous Occlusion Plethysmography: Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
- 8.4.5 Peripheral Arterial Tonometry (PAT)
  - 8.4.5.1 Overview
  - 8.4.5.2 Peripheral Arterial Tonometry (PAT): Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
- 8.4.6 Circulating Markers
  - 8.4.6.1 Overview
  - 8.4.6.2 Circulating Markers: Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
- 8.4.7 Others
  - 8.4.7.1 Overview
  - 8.4.7.2 Others: Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

9. Middle East & Africa Endothelial Dysfunction Market Analysis - by End User

9.1 Overview
9.2 Middle East & Africa Endothelial Dysfunction Market, By End User, 2022 & 2028 (%)
9.3 Hospitals
- 9.3.1 Overview
- 9.3.2 Hospitals: Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
9.4 Diagnostics Centers
- 9.4.1 Overview
- 9.4.2 Diagnostics Centers: Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
9.5 Clinics
- 9.5.1 Overview
- 9.5.2 Clinics: Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Middle East & Africa Endothelial Dysfunction Market Revenue and Forecast to 2028 (US$ Million)

10. Middle East & Africa Endothelial Dysfunction Market - Revenue and Forecast to 2028 - Country Analysis

10.1 Middle East & Africa: Endothelial Dysfunction Market
- 10.1.1 Overview
  - 10.1.1.1 Saudi Arabia: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.1.1 Overview
    - 10.1.1.1.2 Saudi Arabia: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.1.3 Saudi Arabia: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.1.1.1.4 Saudi Arabia: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
    - 10.1.1.1.4.1 Saudi Arabia: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
    - 10.1.1.1.5 Saudi Arabia: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.1.1.2 UAE: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.2.1 Overview
    - 10.1.1.2.2 UAE: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.2.3 UAE: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.1.1.2.4 UAE: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
    - 10.1.1.2.4.1 UAE: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
    - 10.1.1.2.5 UAE: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.1.1.3 South Africa: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.3.1 Overview
    - 10.1.1.3.2 South Africa: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.3.3 South Africa: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.1.1.3.4 South Africa: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
    - 10.1.1.3.4.1 South Africa: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
    - 10.1.1.3.5 South Africa: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)
  - 10.1.1.4 Rest of Middle East & Africa: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.4.1 Overview
    - 10.1.1.4.2 Rest of Middle East & Africa: Endothelial Dysfunction Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.4.3 Rest of Middle East & Africa: Endothelial Dysfunction Market, by Cause, 2020-2028 (US$ Million)
    - 10.1.1.4.4 Rest of Middle East & Africa: Endothelial Dysfunction Market, by Test Type, 2020-2028 (US$ Million)
    - 10.1.1.4.4.1 Rest of Middle East & Africa: Endothelial Dysfunction Market, by Non-Invasive Tests, 2020-2028 (US$ Million)
    - 10.1.1.4.5 Rest of Middle East & Africa: Endothelial Dysfunction Market, by End User 2020-2028 (US$ Million)

11. Middle East & Africa Endothelial Dysfunction Market-Industry Landscape

11.1 Overview
11.2 Growth Strategies in the Endothelial Dysfunction Market
11.3 Inorganic Growth Strategies
- 11.3.1 Overview
11.4 Organic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 ZOLL Medical Corp
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 The Polymath Co
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Perimed AB
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 SMART Medical Ltd
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Medizinische Messtechnik GmbH
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms